Search Results - "RUMSEY, William L"

Refine Results
  1. 1

    Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases by Cuadrado, Antonio, Rojo, Ana I., Wells, Geoffrey, Hayes, John D., Cousin, Sharon P., Rumsey, William L., Attucks, Otis C., Franklin, Stephen, Levonen, Anna-Liisa, Kensler, Thomas W., Dinkova-Kostova, Albena T.

    Published in Nature reviews. Drug discovery (01-04-2019)
    “…The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2 ) and its principal negative regulator, the E3 ligase adaptor Kelch-like…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Cell-free DNA levels associate with COPD exacerbations and mortality by Ware, Sarah A, Kliment, Corrine R, Giordano, Luca, Redding, Kevin M, Rumsey, William L, Bates, Stewart, Zhang, Yingze, Sciurba, Frank C, Nouraie, S Mehdi, Kaufman, Brett A

    Published in Respiratory research (18-01-2024)
    “…Good biological indicators capable of predicting chronic obstructive pulmonary disease (COPD) phenotypes and clinical trajectories are lacking. Because nuclear…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Enhanced mitochondrial DNA repair of the common disease-associated variant, Ser326Cys, of hOGG1 through small molecule intervention by Baptiste, Beverly A., Katchur, Steven R., Fivenson, Elayne M., Croteau, Deborah L., Rumsey, William L., Bohr, Vilhelm A.

    Published in Free radical biology & medicine (20-08-2018)
    “…The common oxidatively generated lesion, 8-oxo-7,8-dihydroguanine (8-oxoGua), is removed from DNA by base excision repair. The glycosylase primarily charged…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists by OHNMACHT, Cyrus J, ALBERT, Jeffrey S, BERNSTEIN, Peter R, RUMSEY, William L, MASEK, Brian B, DEMBOFSKY, Bruce T, KOETHER, Gerard M, ANDISIK, Donald W, AHARONY, David

    Published in Bioorganic & medicinal chemistry (15-05-2004)
    “…Previously we reported on the synthesis and properties of a series of highly potent piperidinyl 2-subsituted-3-cyano-1-naphthamide NK1 antagonists that…”
    Get full text
    Journal Article
  9. 9

    Effects of airborne toxicants on pulmonary function and mitochondrial DNA damage in rodent lungs by Rumsey, William L, Bolognese, Brian, Davis, Alicia B, Flamberg, Pearl L, Foley, Joseph P, Katchur, Steven R, Kotzer, Charles J, Osborn, Ruth R, Podolin, Patricia L

    Published in Mutagenesis (01-05-2017)
    “…Inhalation of airborne toxicants such as cigarette smoke and ozone is a shared health risk among the world's populations. The use of toxic herbicides like…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    The Role of IκB Kinase 2, but Not Activation of NF-κB, in the Release of CXCR3 Ligands from IFN-γ-Stimulated Human Bronchial Epithelial Cells by Tudhope, Susan J., Catley, Matthew C., Fenwick, Peter S., Russell, Richard E. K., Rumsey, William L., Newton, Robert, Barnes, Peter J., Donnelly, Louise E.

    Published in The Journal of immunology (1950) (01-11-2007)
    “…The severity of chronic obstructive pulmonary disease correlates with increased numbers of cytotoxic CD8+ T lymphocytes in the lung parenchyma. CD8+ T…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Imaging of Phosphorescence: A Novel Method for Measuring Oxygen Distribution in Perfused Tissue by Rumsey, William L., Vanderkooi, Jane M., Wilson, David F.

    “…The imaging of phosphorescence provides a method for monitoring oxygen distribution within the vascular system of intact tissues. Isolated rat livers were…”
    Get full text
    Journal Article
  17. 17

    Adaptation to hypoxia alters energy metabolism in rat heart by Rumsey, W L, Abbott, B, Bertelsen, D, Mallamaci, M, Hagan, K, Nelson, D, Erecinska, M

    Published in The American journal of physiology (01-01-1999)
    “…The present study characterized metabolic changes in the heart associated with long-term exposure to hypoxia, a potent stimulus for pulmonary hypertension and…”
    Get full text
    Journal Article
  18. 18

    Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors by Rumsey, W L, Aharony, D, Bialecki, R A, Abbott, B M, Barthlow, H G, Caccese, R, Ghanekar, S, Lengel, D, McCarthy, M, Wenrich, B, Undem, B, Ohnmacht, C, Shenvi, A, Albert, J S, Brown, F, Bernstein, P R, Russell, K

    “…The tachykinins, substance P, neurokinin A, and neurokinin B, have been implicated in many diseases. The present study evaluated the pharmacological properties…”
    Get more information
    Journal Article
  19. 19
  20. 20

    The role of IkappaB kinase 2, but not activation of NF-kappaB, in the release of CXCR3 ligands from IFN-gamma-stimulated human bronchial epithelial cells by Tudhope, Susan J, Catley, Matthew C, Fenwick, Peter S, Russell, Richard E K, Rumsey, William L, Newton, Robert, Barnes, Peter J, Donnelly, Louise E

    Published in The Journal of immunology (1950) (01-11-2007)
    “…The severity of chronic obstructive pulmonary disease correlates with increased numbers of cytotoxic CD8(+) T lymphocytes in the lung parenchyma. CD8(+) T…”
    Get full text
    Journal Article